Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsant-induced dyskinesia.

Megdad M Zaatreh1

  • 1University of North Carolina, Department of Neurology, 3114 Bioinformatics, CB#7025, Chapel Hill, NC 27599-7025, USA. zaatrehm@glial.med.unc.edu

Expert Opinion on Drug Safety
|August 9, 2003
PubMed
Summary

Anticonvulsant-induced dyskinesia (AID) is a common side effect of anticonvulsant medications. Recognizing AID is crucial as it often resolves upon medication discontinuation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Levetiracetam in porphyric status epilepticus: a case report.

Clinical neuropharmacology·2005
Same author

Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome.

Neurology·2003
Same author

Heart rate variability during interictal epileptiform discharges.

Epilepsy research·2003
Same author

Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome.

Epilepsia·2002
Same author

Morphometric and neuropsychologic studies in children with arachnoid cysts.

Pediatric neurology·2002

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Anticonvulsant-induced dyskinesia (AID) is an underdiagnosed adverse effect of anticonvulsant medications.
  • It can occur during initial or chronic treatment, at therapeutic or toxic drug levels.
  • AID may mimic other conditions, leading to extensive diagnostic work-ups.

Purpose of the Study:

  • To highlight the significance of Anticonvulsant-induced dyskinesia (AID).
  • To increase awareness among clinicians regarding this underdiagnosed side effect.
  • To emphasize the importance of recognizing AID due to the increasing use of new anticonvulsants.

Main Methods:

  • Review of clinical presentations and outcomes of AID.
  • Consideration of animal studies suggesting dopaminergic dysfunction in the basal ganglia.
  • Analysis of similarities with other drug-induced dyskinesias.

Main Results:

  • AID is a variable condition, presenting during various treatment phases.
  • Dopaminergic dysfunction in the basal ganglia is implicated in AID.
  • Most cases of dyskinesia associated with anticonvulsants improve after drug withdrawal.

Conclusions:

  • Increased awareness of Anticonvulsant-induced dyskinesia (AID) is essential for timely diagnosis and management.
  • The expanding use of novel anticonvulsants necessitates greater vigilance for AID.
  • Prompt recognition and management, often involving anticonvulsant withdrawal, can lead to favorable outcomes.

Related Experiment Videos